Video Experimental Relacionado
Updated: Jul 25, 2026

07:54
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
Células blancas de la sangre 1: trastornos no malignos
1Department of Medicine, University of Illinois at Chicago School of Medicine, USA.
Lancet (London, England)
|April 25, 2000
Resumen
Los trastornos de los glóbulos blancos son comunes y afectan a la defensa del huésped. Algunas deficiencias hereditarias pueden ser tratables con terapia génica, ofreciendo una nueva esperanza para los pacientes.
Área de la Ciencia:
- Hematología Hematología.
- Inmunología Inmunología.
- Biología celular Biología celular.
Sus antecedentes:
- Los trastornos de los glóbulos blancos se encuentran con frecuencia en entornos clínicos.
- La regulación del desarrollo y el recuento de glóbulos blancos involucra factores externos como las citoquinas, las proteínas de la matriz y las células accesorias.
- Existen distintos linajes de glóbulos blancos, cada uno crucial para los mecanismos de defensa del huésped.
Objetivo del estudio:
- Para revisar los trastornos comunes de los glóbulos blancos.
- Discutir los mecanismos reguladores del desarrollo y número de glóbulos blancos.
- Para resaltar el potencial de la terapia génica para las deficiencias hereditarias de glóbulos blancos.
Principales métodos:
- Revisión de la literatura sobre trastornos de los glóbulos blancos.
- Análisis de las vías reguladoras en la hematopoyesis.
- Examen de estrategias terapéuticas actuales y emergentes, incluida la terapia génica.
Principales resultados:
- Los trastornos de los glóbulos blancos se manifiestan como deficiencia o sobreproducción.
- Los estímulos externos complejos gobiernan la homeostasis de los glóbulos blancos.
- La terapia génica es prometedora para deficiencias específicas de glóbulos blancos heredados.
Conclusiones:
- Los trastornos de los glóbulos blancos son clínicamente significativos y diversos.
- La comprensión de los mecanismos reguladores es clave para abordar las anomalías de los glóbulos blancos.
- La terapia génica representa un posible tratamiento futuro para ciertos trastornos hereditarios de los glóbulos blancos.
Videos de Conceptos Relacionados
Cell-mediated Immune Responses
Overview
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Structure and Function of Leukocytes
An adult in good health typically has between 4,500 and 11,000 leukocytes, or white blood cells, per microliter of blood, which constitutes about 1% of the total blood volume. Unlike red blood cells, white blood cells contain a nucleus and other cellular organelles but do not have hemoglobin. Most white blood cells reside in connective tissues, particularly in lymphatic organs such as the lymph nodes, with only a small fraction present in circulating blood.
White blood cells protect the body...
White blood cells protect the body...
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

